-Provides update from ongoing Phase 1/2 clinical trials of CTX001® for patients with severe hemoglobinopathies--Began treating patients in Phase 1/2 […]
TORONTO, Oct. 28, 2019 (GLOBE NEWSWIRE) — NextSource Materials Inc. (TSX:NEXT) (OTCQB:NSRCF) (“NextSource” or the “Company”) announces it has completed […]
VANCOUVER, Colombie-Britannique, 28 oct. 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) [...]